SGLT2 inhibitors on every 2026 Guam Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Guam cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$0.00/moS5820-035 |
|---|---|
| Jardianceempagliflozin | Tier 325%QL 30/30d |
| Farxigadapagliflozin | Not covered |
| dapagliflozingeneric Farxiga | Tier 325%QL 30/30d |
| Invokanacanagliflozin | Not covered |
| Steglatroertugliflozin | Not covered |
| Inpefasotagliflozin | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.